An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

por Talaat, Kawsar R., Karron, Ruth A., Liang, Philana H., McMahon, Bridget A., Luke, Catherine J., Thumar, Bhagvanji, Chen, Grace L., Min, Ji‐Young, Lamirande, Elaine W., Jin, Hong, Coelingh, Kathy L., Kemble, George W., Subbarao, Kanta
Publicado 2012